AllianceBernstein L.P.-AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for Unites States patent covering masitinib until 2040 in the treatment of sickle cell disease

AllianceBernstein L.P.(AB) GlobeNewswire·2025-04-15 00:02